ArticleAlzheimer's research & therapy2022

Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.

Chad J Swanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.